Quantum model achieved 91.9% accuracy in preliminary lung cancer prediction tests using 108 training samples from an augmented dataset. Clinical validation is still pending.
Key points
Accuracy: 91.9% on preliminary tests.
Training data: 108 samples from an augmented dataset.
Sources
- Original post
- medicalxpress.com - Linked in the post
OpenMed GLiNER2.5 ClinicalNER Disease Spanish fine-tuned, F1 39.1-73.3
OpenMed GLiNER2.5 ClinicalNER Disease Spanish v1 is an open model for disease extraction in Spanish clinical text. After fine-tuning it reaches an F1 range of 39.1 to 73.3. It is released under the Apache-2.0 license.
Key points
F1 score after fine-tuning: 39.1 – 73.3
License: Apache-2.0
Detects four disease mentions (HTA, DM2, EPOC, IC) at exact character offsets
Model size: 0.3B parameters, runs on CPU.
Sources
Calcium treatments 19% larger stent areas vs shockwave
Calcium treatments produced about 19% larger coronary stent areas compared to shockwave treatment alone in patients with calcified nodules. Longer-term benefits are unproven.
Key points
19% larger coronary stent areas with combined calcium treatments vs shockwave
Longer-term benefits remain unproven
Sources
- Original post
- medicalxpress.com - Linked in the post
Spendrule seed round raises $4M from Radical and ZealVC
Spendrule announced a $4 million seed round backed by Radical Investments and ZealVC. The AI platform checks health system invoices against contracts and flags overcharges.
Key points
Funding: $4M seed round
Investors: Radical Investments (including @mcuban) and ZealVC
Sources
Vorelios launch – research lab building AI that engineers anything
Vorelios announced its launch as a YC F26 research lab building AI that can engineer anything. The lab claims its models predict design behavior in seconds and use those predictions to invent and improve designs autonomously.
Key points
Launch: Vorelios is now live as a YC F26 company.
Claim: Models predict a design’s behavior in seconds and use predictions to autonomously invent and improve designs.
Sources
- Original post
- vorelios.com - Linked in the post
Glucose-sensing component cost one-tenth, performance comparable
Glucose-sensing component delivers comparable performance at roughly one-tenth the cost of an earlier alternative. The injectable sensor is still a proof of concept.
Key points
Performance: comparable to earlier alternative
Cost: roughly one-tenth the cost of earlier alternative
Status: injectable sensor remains a proof of concept
Sources
- Original post
- medicalxpress.com - Linked in the post
insitro's Daphne Koller appears on The Long Run podcast
insitro's Daphne Koller appears on The Long Run podcast as the latest guest. The episode is sponsored by AlphaSenseInc and Dash Bio.
Key points
Guest: Daphne Koller of insitro
Sponsors: AlphaSenseInc and Dash Bio
Sources
- Original post
- timmermanreport.com - Linked in the post
DoseCheck™ added to Doximity Ask dosing tool
DoseCheck™ is now available in Doximity Ask, giving physicians a built-in dosing check with source references. No language model is used, so there is no hallucination.
Key points
Feature: built-in check on dosing in Doximity Ask
Claim: no language model is involved, so there is no hallucination